ICE-R regimen

WikiDoc Resources for ICE-R regimen

Articles

Most recent articles on ICE-R regimen

Most cited articles on ICE-R regimen

Review articles on ICE-R regimen

Articles on ICE-R regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on ICE-R regimen

Images of ICE-R regimen

Photos of ICE-R regimen

Podcasts & MP3s on ICE-R regimen

Videos on ICE-R regimen

Evidence Based Medicine

Cochrane Collaboration on ICE-R regimen

Bandolier on ICE-R regimen

TRIP on ICE-R regimen

Clinical Trials

Ongoing Trials on ICE-R regimen at Clinical Trials.gov

Trial results on ICE-R regimen

Clinical Trials on ICE-R regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on ICE-R regimen

NICE Guidance on ICE-R regimen

NHS PRODIGY Guidance

FDA on ICE-R regimen

CDC on ICE-R regimen

Books

Books on ICE-R regimen

News

ICE-R regimen in the news

Be alerted to news on ICE-R regimen

News trends on ICE-R regimen

Commentary

Blogs on ICE-R regimen

Definitions

Definitions of ICE-R regimen

Patient Resources / Community

Patient resources on ICE-R regimen

Discussion groups on ICE-R regimen

Patient Handouts on ICE-R regimen

Directions to Hospitals Treating ICE-R regimen

Risk calculators and risk factors for ICE-R regimen

Healthcare Provider Resources

Symptoms of ICE-R regimen

Causes & Risk Factors for ICE-R regimen

Diagnostic studies for ICE-R regimen

Treatment of ICE-R regimen

Continuing Medical Education (CME)

CME Programs on ICE-R regimen

International

ICE-R regimen en Espanol

ICE-R regimen en Francais

Business

ICE-R regimen in the Marketplace

Patents on ICE-R regimen

Experimental / Informatics

List of terms related to ICE-R regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:R-ICE Regimen; RICE Regimen; Rituximab-Ifosfamide-Carboplatin-Etoposide Regimen

## Overview[edit | edit source]

ICE-R regimen refers to a chemoimmunotherapy regimen consisting of rituximab, ifosfamide, carboplatin and etoposide used to treat indolent and aggressive forms of non-Hodgkin's lymphoma; also used to treat relapsed and refractory non-Hodgkin's lymphoma.[1][2]

## Regimen[edit | edit source]

RRituximab

IIfosfamide

CCarboplatin

EEtoposide

## Indications[edit | edit source]

* Relapsed and refractory non-Hodgkin's lymphoma.[1]

## References[edit | edit source]

1. ↑ 1.0 1.1 Vose J, Sneller V (2003). "Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma". Ann Oncol. 14 Suppl 1: i17–20. PMID 12736226.
2. ↑ "NCI Thesaurus".